# A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia

> **NCT01626924** · PHASE2 · TERMINATED · sponsor: **Neurophyxia B.V.** · enrollment: 6 (actual)

## Conditions studied

- Perinatal Asphyxia

## Interventions

- **DRUG:** 2-Iminobiotin

## Key facts

- **NCT ID:** NCT01626924
- **Lead sponsor:** Neurophyxia B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2014-10
- **Final completion:** 2016-03
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Recruitment too slow and site decided to use hypothermia (exclusion criteria)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626924, "A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01626924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*